Sheppard Mullin advised RK Pharma on the deal.RK Pharma Inc., a U.S.-based vertically integrated pharmaceutical company, announced its $200 million investment from PAG, a leading Asia-Pacific…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
